Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 20 recruiting now official registry

Venous Leg Ulcer clinical trials

Every US clinical trial registered for Venous Leg Ulcer — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

36 US clinical trials · 20 currently recruiting

The research picture

Venous Leg Ulcer has 36 registered US clinical trials, 20 of them open to new participants right now — about 56% of the total.

20
recruiting participants now
56%
of trials open to enrollment
8
in Phase 3–4 (later-stage)
3
top sponsor: BioLab Holdings

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING Phase 4 650 participants

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

BioLab Holdings

NCT07089602

RECRUITING NA 350 participants

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Integra LifeSciences Corporation

NCT06453187

RECRUITING Phase 4 340 participants

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Tiger Biosciences

NCT06826339

RECRUITING NA 324 participants

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

Stability Biologics

NCT06560502

RECRUITING Phase 3 312 participants

Tissue Repair Gel in Venous Leg Ulcers in AU/US

TR Therapeutics

NCT06707103

RECRUITING Phase 3 312 participants

Tissue Repair Gel in Venous Leg Ulcers (US)

TR Therapeutics

NCT06707090

RECRUITING NA 180 participants

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

Surgenex

NCT06515093

RECRUITING NA 180 participants

Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center

Medaxis

NCT04920253

RECRUITING NA 165 participants

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

W.L.Gore & Associates

NCT05489588

RECRUITING NA 165 participants

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

Capsicure

NCT07046767

RECRUITING NA 150 participants

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

BioLab Holdings

NCT06544564

RECRUITING 150 participants

Evaluating the Durability of Closure for Venous Leg Ulcers

Kerecis

NCT06697925

RECRUITING NA 120 participants

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

ConvaTec

NCT06606210

RECRUITING NA 68 participants

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Molnlycke Health Care AB

NCT05588583

RECRUITING NA 60 participants

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

BioStem Technologies

NCT06811909

RECRUITING Phase 4 50 participants

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

BioLab Holdings

NCT07364630

RECRUITING Phase 2 50 participants

Dermacyte® Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers

Merakris Therapeutics

NCT04647240

RECRUITING NA 20 participants

Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy

Wake Forest University Health Sciences

NCT03716167

RECRUITING NA 20 participants

A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing

Molnlycke Health Care AB

NCT05608317

RECRUITING NA 10 participants

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

NuScience Medical Biologics

NCT07061613

ACTIVE NOT RECRUITING 2,500 participants

Geko™ Cross Therapy Registry - Wound

Firstkind

NCT05007301

ACTIVE NOT RECRUITING Phase 4 292 participants

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

Cellution Biologics

NCT06562296

ACTIVE NOT RECRUITING Phase 3 250 participants

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

RHEACELL GmbH & Co. KG

NCT06489028

ACTIVE NOT RECRUITING NA 225 participants

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

Washington University School of Medicine

NCT03250247

ACTIVE NOT RECRUITING NA 136 participants

Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers

University of Miami

NCT03796793

ACTIVE NOT RECRUITING NA 112 participants

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study

W.L.Gore & Associates

NCT05409976

ACTIVE NOT RECRUITING Phase 2 80 participants

Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers

SerenaGroup

NCT03154619

COMPLETED Phase 3 537 participants

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

Organogenesis

NCT00909870

COMPLETED NA 200 participants

Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers

Osiris Therapeutics

NCT03629236

COMPLETED NA 136 participants

Intermittent Pneumatic Compression of the Thigh

Huntleigh Healthcare

NCT05659394

COMPLETED Phase 2 121 participants

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Ilkos Therapeutic

NCT03077165

COMPLETED Phase 2 120 participants

A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

MediWound

NCT03588130

COMPLETED NA 98 participants

Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers

MiMedx Group

NCT01552447

COMPLETED NA 54 participants

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

Omeza

NCT05291169

COMPLETED NA 28 participants

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

Tactile Medical

NCT02395302

COMPLETED Phase 1 10 participants

Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers

Xequel Bio

NCT02652572

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 4
Phase 3 4
Phase 4 4

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Venous Leg Ulcer Trial Landscape

ClinicalTrials.gov lists 36 US studies indexed under Venous Leg Ulcer, and 20 of those are currently open to recruitment — roughly 56% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Venous Leg Ulcer shows 8 late-stage studies (Phase 3 and Phase 4 combined) alongside 5 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Venous Leg Ulcer is led by BioLab Holdings with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 36 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Venous Leg Ulcer?

PlainTrial tracks 36 US clinical trials for Venous Leg Ulcer, of which 20 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Venous Leg Ulcer?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →